Alzheimer's Disease Related Antibodies

Alzheimer's disease (AD), the most common type of dementia, is projected to triple in prevalence by 2050, posing a major worldwide health concern with significant implications for individuals and society. The initial symptoms of AD are insidious, progressive problems centered on episodic memory. The criteria for amnestic-moderate cognitive impairment (MCI) may be met at this point. Memory challenges, loss of confidence, and difficulties multitasking follow. Cognitive impairments become severe and pervasive as the condition progresses, even interfering with regular life tasks. At this time, patients can be diagnosed with Alzheimer's disease dementia. Learn more about Alzheimer's Disease related antibodies